References
- Foon KA, Rai KR, Gale RP. Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med 1990;113:525–539.
- O’Brien S, del Giglio A, Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 199585:307–318.
- Mauro FR, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E, et al. Clinical characteristics and out-come of young chronic lymphocytic leukemia patients: A single institution study of 204 cases. Blood 1999;94(2): 448–454.
- Montserrat E, Gomis F, Vallespi T, Rios A, Romero A, Soler J, et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 1991;78:1545–1551.
- Pangalis GA, Reverter JC, Boussiotis VA, Montserrat E. Chronic lymphocytic leukemia in younger adults: Preliminary results of a study based on 454 patients. IWCLL/Working Group. Leuk Lymphoma 1991;5\(suppl 1):175.
- Dhodapkar M, Tefferi A, Su J, Phyliky RL. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): A single institution study. Leukemia 19937:1232–1235.
- Molica S, Brugiatelli M, Callea V, Morabito F, Levato D, Nobile F, Alberti A. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases. Eur J Haematol 199452:216–221.
- Cheson BD, Bennett JM, Greyer M, Kay N, Keating MJ, O’Brien S, et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996;87(12): 4990–4997.
- Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternak BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
- Brugiatelli M, Claisse JF, Lenormand B, Morabito F, Callea V, Malloum K, Chevret S, Binet JL, Dighiero G, Travade P. Long-term outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level. Br J Haematol 1997;97:113–118.
- The French Cooperative Group on CLL, Johnson S, Smith AG, Loffier H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and pre-dnisone (CAP) for treatment of advanced-stage chronic lymphocytic lekaemia. Lancet 1996;347:1432–1438.
- Keating MJ, O’Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998;92:1165–1171.
- Catovsky D, Richards S, Fooks J, Hamblin TJ. CLL trials in the United Kingdom: MRC trial 1, 2 and 3. Leuk Lymphoma 1991;5\(suppl 14):105.
- Dighiero G, Maloum K, Desablens B, et al. Chlorambucil in indolent chronic lymphocytic leukemia. N Engl J Med 1998; 338:1506–1514.
- Keller JW, Knospe WH, Raney M, Huguley CM Jr, Johnson L, Bartolucci AA, et al. Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle active consolidation chemotherapy. Cancer 1986;58: 1185–1192.
- Raphael B, Andersen JVI, Silber R, Oken M, Moore D, BennettJ, et al. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treat-ment for chronic lymphocytic leukemia: Long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. J Clin Oncol 1991;9:770–776.
- Montserrat E, Alcala A, Parody R, Domingo A, Garcia-Conde J, Bueno J, et al. Spanish Cooperative Group for Hematologi-cal Malignancies Treatment Spanish Society of Hematology: Treatment of chronic lymphocytic leukemia in advanced stages. Cancer 1985;56:2369–2375.
- Lee JS, Dixon DO, Kantarjian HM, Keating MJ, Talpaz M. Prognosis of chronic lymphocytic leukemia: A multivariate regression analysis of 325 untreated patients. Blood 1987; 69(3):929–936.